The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Update on the endorsement of CONSORT by high impact factor journals: a survey of journal “Instructions to Authors” in 2014
Open accessAbstract
BACKGROUND: The CONsolidated Standards Of Reporting Trials (CONSORT) Statement provides a minimum standard set of items to be reported in published clinical trials; it has received widespread recognition within the biomedical publishing community. This research aims to provide an update on the endorsement of CONSORT by high impact medical journals. METHODS: We performed a cross-sectional examination of the online "Instructions to Authors" of 168 high impact factor (2012) biomedical journals between July and December 2014. We assessed whether the text of the "Instructions to Authors" mentioned the CONSORT Statement and any CONSORT extensions, and we quantified the extent and nature of the journals' endorsements of these. These data were described by frequencies. We also determined whether journals mentioned trial registration and the International Committee of Medical Journal Editors (ICMJE; other than in regards to trial registration) and whether either of these was associated with CONSORT endorsement (relative risk and 95 % confidence interval). We compared our findings to the two previous iterations of this survey (in 2003 and 2007). We also identified the publishers of the included journals. RESULTS: Sixty-three percent (106/168) of the included journals mentioned CONSORT in their "Instructions to Authors." Forty-four endorsers (42 %) explicitly stated that authors "must" use CONSORT to prepare their trial manuscript, 38 % required an accompanying completed CONSORT checklist as a condition of submission, and 39 % explicitly requested the inclusion of a flow diagram with the submission. CONSORT extensions were endorsed by very few journals. One hundred and thirty journals (77 %) mentioned ICMJE, and 106 (63 %) mentioned trial registration. CONCLUSIONS: The endorsement of CONSORT by high impact journals has increased over time; however, specific instructions on how CONSORT should be used by authors are inconsistent across journals and publishers. Publishers and journals should encourage authors to use CONSORT and set clear expectations for authors about compliance with CONSORT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Considering that the statement encourages both the registration of studies and the declaration of funding and conflicts of interest, we can expect higher reporting of these characteristics compared to the sharing of data and codes.”
From Assessing transparency practices in dental randomized controlled trials (2024) · cites this paper as [38]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“While they have been endorsed by many high impact journals10, adherence to reporting guidelines remains inadequate2,11,12.”
From Text classification models for assessing the completeness of randomized controlled trial publications based on CONSORT reporting guidelines (2024) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Endorsement of the use of the CONSORT statement [38, 39] has been observed for many years and is prevalent in many journals.”
From Assessing transparency practices in dental randomized controlled trials (2024) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Self-citationCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329
Self-citationMoher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883 · cited 2×
“Specifically, we extracted information on whether CONSORT and/or its extensions (for abstracts [10], acupuncture trials [11], cluster trials [12], harms outcomes [13], herbal interventions [14], noninferiority and equivalence trials [15], nonpharmacological interventions [16], patient-reported outcomes [17], and pragm…”
BackgroundMethodSelf-citationThe Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835 · cited 2×
“Specifically, we extracted information on whether CONSORT and/or its extensions (for abstracts [10], acupuncture trials [11], cluster trials [12], harms outcomes [13], herbal interventions [14], noninferiority and equivalence trials [15], nonpharmacological interventions [16], patient-reported outcomes [17], and pragm…”
BackgroundMethodSelf-citationConsort 2010 statement: extension to cluster randomised trials
Campbell, M. K., Piaggio, G., Elbourne, D. R., Altman, D. G., & for the CONSORT Group (2012) · BMJ · doi:10.1136/bmj.e5661 · Cited by 3,510
Self-citationImproving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755 · cited 2×
“Specifically, we extracted information on whether CONSORT and/or its extensions (for abstracts [10], acupuncture trials [11], cluster trials [12], harms outcomes [13], herbal interventions [14], noninferiority and equivalence trials [15], nonpharmacological interventions [16], patient-reported outcomes [17], and pragm…”
BackgroundMethodSelf-citationMoher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Self-citationPiaggio, G., Elbourne, D. R., Pocock, S. J., Evans, S. J. W., Altman, D. G., & CONSORT Group, F. T. (2012) · JAMA · doi:10.1001/jama.2012.87802 · Cited by 2,428 · cited 1×
“Specifically, we extracted information on whether CONSORT and/or its extensions (for abstracts [10], acupuncture trials [11], cluster trials [12], harms outcomes [13], herbal interventions [14], noninferiority and equivalence trials [15], nonpharmacological interventions [16], patient-reported outcomes [17], and pragm…”
MethodSelf-citationBoutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00008 · Cited by 2,292
Self-citation
Cited by
CONSORT 2010 statement: extension to randomised crossover trials
Dwan, K., Li, T., Altman, D. G., & Elbourne, D. (2019) · BMJ · doi:10.1136/bmj.l4378 · Cited by 785
Self-citationO. B. O. T. C.-S. G., Grant, S., Mayo-Wilson, E., Montgomery, P., Macdonald, G., Michie, S., Hopewell, S., & Moher, D. (2018) · Trials · doi:10.1186/s13063-018-2735-z · Cited by 348
Self-citationCONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials
Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081124 · Cited by 205
Self-citationDechartres, A., Trinquart, L., Atal, I., Moher, D., Dickersin, K., Boutron, I., Perrodeau, E., Altman, D. G., & Ravaud, P. (2017) · BMJ · doi:10.1136/bmj.j2490 · Cited by 171
Self-citationTREND Reporting Guidelines for Nonrandomized/Quasi-Experimental Study Designs
Haynes, A. B., Haukoos, J. S., & Dimick, J. B. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.0552 · Cited by 139
Metadata
- Authors
- Shamseer, L., Hopewell, S., Altman, D. G., Moher, D., & Schulz, K. F.
- Affiliations
- University of Ottawa (CA)
- University of Oxford (GB)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Shamseer, Larissa
- Venue
- Trials
- Published
- 2016-06-24
- Volume
- 17
- Issue
- 1
- Pages
- 301-301
- ISSN
- 1745-6215 (ISSN-L)
- PMC
- PMC4921029
- OpenAlex
- W2460394012
- Cited by
- 168
- References
- 30
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 20 · 2023: 18 · 2022: 18 · 2021: 20 · 2020: 21 · 2019: 17 · 2018: 11 · 2017: 15 · 2016: 3
- FWCI
- 14.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Trials (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- uO Research (University of Ottawa) (submittedVersion, public-domain)
- Funders
- Medical Research Council (MR/J004871/1)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Social Sciences › Library and Information Sciences › Academic Writing and Publishing
- Keywords
- CONSORT statement, reporting guidelines, clinical trial reporting, CONSORT extension, clinical trial registration, ICMJE, CONSORT checklist, flowcharts, biomedical journals
- MeSH terms
- Clinical Trials as Topic, Cross-Sectional Studies, Humans, Periodicals as Topic, Journal Impact Factor, Research Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Update on the endorsement of CONSORT by high impact factor journals: a survey of journal “Instructions to Authors” in 2014. https://app.cochat.ai/papers/10.1186/s13063-016-1408-z
- The paper
- Shamseer, L., Hopewell, S., Altman, D. G., Moher, D., & Schulz, K. F. (2016). Update on the endorsement of CONSORT by high impact factor journals: a survey of journal “Instructions to Authors” in 2014. Trials. https://doi.org/10.1186/s13063-016-1408-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.